Safety of Alternative Benznidazole and Nifurtimox Regimens for Adults with Chronic Trypanosoma Cruzi Infection (TESEO): An Open-Label, Randomised, Non-Inferiority Phase 2 Trial

Simple item page
dc.contributor.authorCristina Alonso-Vega
dc.contributor.authorJimy José Pinto
dc.contributor.authorGimena Rojas
dc.contributor.authorWilson García
dc.contributor.authorAlejandro Palacios
dc.contributor.authorSusana Méndez
dc.contributor.authorVirginia Gonzalez
dc.contributor.authorMónica Laserna
dc.contributor.authorIsabela Ribeiro
dc.contributor.authorE. Ruíz-Villamor
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T20:52:58Z
dc.date.available2026-03-22T20:52:58Z
dc.date.issued2026
dc.identifier.doi10.2139/ssrn.6311846
dc.identifier.urihttps://doi.org/10.2139/ssrn.6311846
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/84630
dc.publisherRELX Group (Netherlands)
dc.relation.ispartofSSRN Electronic Journal
dc.sourceBarcelona Institute for Global Health
dc.subjectBenznidazole
dc.subjectNifurtimox
dc.subjectTolerability
dc.subjectMedicine
dc.subjectDiscontinuation
dc.subjectInternal medicine
dc.subjectRegimen
dc.subjectAdverse effect
dc.subjectChagas disease
dc.subjectTrypanosoma cruzi
dc.titleSafety of Alternative Benznidazole and Nifurtimox Regimens for Adults with Chronic Trypanosoma Cruzi Infection (TESEO): An Open-Label, Randomised, Non-Inferiority Phase 2 Trial
dc.typepreprint

Files

Collections

Artículo Científico (Preprint)